Skip to main content

Want a detailed portfolio tracker?

Praxis Precision Medicines (PRAX) P/E (2020 - 2026)

Praxis Precision Medicines (PRAX) P/E from Oct 16, 2020 to Jul 20, 2026. The TTM Praxis Precision Medicines (PRAX) P/E is -22.18. You can export chart.

All data is split-adjusted. You can find the most accurate data from the reports on the SEC official website. We recommend verify information using official company filings before making investment decisions.

P/E

Annual P/E change of Praxis Precision Medicines (PRAX)

YearP/EChange
2026-22.18+3.92%
2025-21.34+21.25%
2024-17.60-1950.11%
20230.95-206.56%
2022-0.89-93.57%
2021-13.88-54.90%
2020-30.78N/A

Comparison Praxis Precision Medicines (PRAX) P/E with competitors

Praxis Precision Medicines (PRAX) P/E is -22.18.

TickerNameP/EUpside
SPRCSciSparc Ltd0.00-100.01%
NBYStablecoin Development Corp0.00-100.02%
ENLVEnlivex Ltd0.07-100.34%
FGENFibroGen Inc0.24-101.08%
CHRSCoherus Biosciences Inc0.85-103.83%
FBIOFortress Biotech Inc0.95-104.28%
ORMPOramed Pharmaceuticals Inc1.50-106.78%
AGENAgenus Inc3.01-113.57%
INVAInnoviva Inc3.15-114.22%
VXRTVaxart Inc3.55-116.00%
CRMDCorMedix Inc3.63-116.36%
CVACCureVac N.V.4.45-120.04%
GLPGGalapagos NV4.86-121.90%
SRPTSarepta Therapeutics Inc4.88-122.01%
ABEOAbeona Therapeutics Inc5.39-124.29%
ABUSArbutus Biopharma Corp5.60-125.23%
ZVRAZevra Therapeutics Inc5.89-126.54%
SPROSpero Therapeutics Inc6.23-128.08%
CGENCompugen Ltd6.31-128.46%
RIGLRigel Pharmaceuticals6.87-130.98%
SLXNSilexion Therapeutics Corp7.30-132.89%
OMEROmeros Corporation9.26-141.74%
AUPHAurinia Pharmaceuticals Inc9.58-143.21%
PLXProtalix BioTherapeutics Inc10.89-149.10%
ACADAcadia Pharmaceuticals Inc11.73-152.87%
TBPHTheravance Biopharma Inc12.26-155.28%
ADMAAdma Biologics Inc12.42-155.98%
HRMYHarmony Biosciences Holdings Inc13.82-162.30%
SABSSAB Biotherapeutics Inc14.14-163.73%
NAGENiagen Bioscience Inc14.82-166.80%
INCYIncyte Corp15.82-171.33%
REGNRegeneron Pharmaceuticals Inc15.86-171.48%
PBYIPuma Biotechnology Inc17.32-178.06%
CPRXCatalyst Pharmaceuticals Inc17.44-178.62%
EXELExelixis Inc17.54-179.06%
TGTXTG Therapeutics Inc18.97-185.50%
MDXGMimedx Group Inc20.55-192.65%
XOMAXOMA Royalty Corp22.87-203.13%
ARGXArgen X SE24.30-209.54%
CTMXCytomX Therapeutics Inc24.82-211.90%
XOMAOXOMA Royalty Corp25.34-214.26%
HALOHalozyme Therapeutics Inc25.62-215.52%
XOMAPXOMA Royalty Corp25.67-215.73%
VRTXVertex Pharmaceuticals Inc27.99-226.21%
RPRXRoyalty Pharma plc - Class A28.69-229.33%
SLNOSoleno Therapeutics Inc29.02-230.81%
ASNDAscendis Pharma A/S30.09-235.63%
LGNDLigand Pharmaceuticals Inc - Class B37.91-270.92%
APLSApellis Pharmaceuticals Inc39.02-275.92%
BMRNBiomarin Pharmaceutical Inc42.21-290.30%
KRYSKrystal Biotech Inc45.34-304.42%
ONCBeiGene Ltd69.54-413.51%
PHARPharming Group N.V.75.03-438.24%
TECHBio-Techne Corp101.96-559.66%
VCELVericel Corp109.92-595.56%
ALNYAlnylam Pharmaceuticals Inc117.96-631.82%
GMABGenmab140.29-732.47%
TLXTelix Pharmaceuticals Ltd162.15-831.04%
CORTCorcept Therapeutics Inc212.86-1059.63%